North Carolina GranuFlo and NaturaLyte Injury Lawyers
Kidney dialysis patients who have received improper doses of GranuFlo Dry Acid Concentrate and NaturaLyte Liquid Acid Concentrate to replace amino acids lost during the hemodialysis procedure have suffered potentially deadly reactions.
The U.S. Food and Drug Administration (FDA) has issued a Class I recall of these defective medical products. Class I recalls are the most serious type of recall. They involve situations in which there is a reasonable probability that use of the recalled products will cause serious adverse health consequences or death.
GranuFlo Dry Acid Concentrate and NaturaLyte Liquid Acid Concentrate contribute to elevated bicarbonate levels if they are administered in improper doses. Elevated bicarbonate levels can lead to blood irregularities, heart arrhythmia and heart attack. Left untreated, metabolic alkalosis will lead to convulsions, heart failure and coma.
If you are a kidney dialysis (hemodialysis) patient or the family member of a dialysis patient who was harmed by GranuFlo or NaturaLyte, you may be entitled to compensation for medical expenses, pain and suffering, emotional distress, lost wages, future expenses and more.
Contact the North Carolina GranuFlo and NaturaLyte injury lawyers at Hardison & Cochran toll free at (800) 434-8399 today or through our online contact form. You’ll hear from us within 24 hours, and your initial consultation will be free.
GranuFlo and NaturaLyte Linked to Potentially Deadly Complications
GranuFlo Dry Acid Concentrate and NaturaLyte Liquid Acid Concentrate are supplements given to kidney dialysis patient to replace amino acids that are naturally lost during hemodialysis sessions. But the FDA said in March 2012 that if GranuFlo and NaturaLyte are administered in improper doses, they can contribute to elevated bicarbonate levels in dialysis patients.
Elevated bicarbonate levels in a person’s body can cause metabolic alkalosis, a pH imbalance in which the body has accumulated too much of an alkaline substance.
Metabolic alkalosis is considered a risk factor for several conditions, including:
- Cardiopulmonary arrest (heart attack)
- Cardiac arrhythmia (irregular heart rate)
- Hypoxemia (low blood oxygen)
- Hypercapnia (increased carbon dioxide in the blood)
- Hypokalemia (low potassium levels in the blood)
- Hypotension (low blood pressure).
If it is left untreated, metabolic alkalosis may lead to convulsions, heart failure and coma.
The FDA issued a Class 1 recall, the agency’s highest level of recall, for GranuFlo and NaturaLyte on March 29, 2012. “This product may cause serious adverse health consequences, including death,” the FDA said.
Fresenius Medical Care North America of Waltham, Massachusetts, alerted its own physicians and medical directors in November 2011 that GranuFlo “appeared to be contributing to a sharp increase in the risk of patients dying suddenly from cardiac arrest,” the FDA discovered later.
Medical product manufacturers are bound by law to ensure their products perform as marketed. If a patient is harmed because of a defective medical product, the manufacturer of the product may be found liable for damages. If you or someone you love has been injured by a defective medical product, you have the right to seek compensation for the injuries and losses suffered.
To ensure that your rights are protected, you should be represented by a qualified defective medical products attorney such as those at Hardison & Cochran.
Contact a North Carolina GranuFlo and NaturaLyte Injury Lawyer Today
If you or a loved one has had a serious adverse reaction after the administration of GranuFlo Dry Acid Concentrate or NaturaLyte Liquid Acid Concentrate during kidney dialysis (hemodialysis), you may be entitled to compensation for your losses.
We represent victims of faulty medical products in Raleigh, Cary, Wake County, Research Triangle Park, Durham and elsewhere in the Triangle, as well as in Fayetteville, Dunn, Southern Pines, Wilmington, Person County, Greensboro and the Triad, and throughout the state of North Carolina.